Literature DB >> 25929437

Inflammation, a link between obesity and atrial fibrillation.

Alina Scridon1, Dan Dobreanu, Philippe Chevalier, Răzvan Constantin Şerban.   

Abstract

Despite the long belief that the role of the adipose tissue was restricted to that of a passive store of triglycerides and a rich source of fatty acids, accumulating data demonstrates that the adipose tissue acts as an endocrine organ, capable of producing a large number of cytokines incriminated in generating a systemic inflammatory status. At its turn, this adiposity-related pro-inflammatory status appears to promote a large range of cardiovascular disorders, including atrial fibrillation (AF). Recent studies suggest that, in addition to systemic adiposity, the volume of the pericardial fat of the entire heart, and particularly of that overlying the atria, may represent an even more important risk factor for AF. This review focuses on the most relevant clinical and experimental data that bridge adiposity-induced inflammation and AF, and provides, through a multidisciplinary approach, a discussion that integrates both the current knowledge regarding the prolific activity of systemic and pericardial adipose tissue as sources of inflammatory mediators and the main effects of adiposity-induced inflammation on the most relevant electrophysiological, structural, and autonomic mechanisms responsible for AF.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25929437     DOI: 10.1007/s00011-015-0827-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  75 in total

1.  Is visceral adiposity the "enemy within"?

Authors:  R P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-06       Impact factor: 8.311

2.  Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1.

Authors:  Giuseppina Mattace Raso; Maria Pacilio; Emanuela Esposito; Anna Coppola; Raffaele Di Carlo; Rosaria Meli
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  Body fat and sympathetic nerve activity in healthy subjects.

Authors:  U Scherrer; D Randin; L Tappy; P Vollenweider; E Jéquier; P Nicod
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

4.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  Lars Frost; Lone Juul Hune; Peter Vestergaard
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

5.  Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes.

Authors:  T Morgera; A Di Lenarda; L Dreas; B Pinamonti; F Humar; R Bussani; F Silvestri; D Chersevani; F Camerini
Journal:  Am Heart J       Date:  1992-08       Impact factor: 4.749

6.  Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.

Authors:  Haruyasu Ito; Koh Ono; Ryousuke Nishio; Shigetake Sasayama; Akira Matsumori
Journal:  Cytokine       Date:  2002-02-21       Impact factor: 3.861

7.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

8.  Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.

Authors:  Luigi Fontana; J Christopher Eagon; Maria E Trujillo; Philipp E Scherer; Samuel Klein
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

9.  Atrial fibrillation and obesity--results of a meta-analysis.

Authors:  Nikolas Wanahita; Franz H Messerli; Sripal Bangalore; Apoor S Gami; Virend K Somers; Jonathan S Steinberg
Journal:  Am Heart J       Date:  2007-12-19       Impact factor: 4.749

10.  Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity.

Authors:  Gianluca Iacobellis; Maria Cristina Ribaudo; Gaetano Leto; Alessandra Zappaterreno; Elio Vecci; Umberto Di Mario; Frida Leonetti
Journal:  Obes Res       Date:  2002-08
View more
  14 in total

1.  Effect of corticosteroids on atrial fibrillation after catheter ablation: a meta-analysis.

Authors:  Sanjay Jaiswal; Xian-Bao Liu; Qu-Cheng Wei; Ying-Hao Sun; Li-Han Wang; Liu-Guang Song; Dan-Dan Yang; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

2.  Accumulation of Pericardial Fat Is Associated With Alterations in Heart Rate Variability Patterns in Hypercholesterolemic Pigs.

Authors:  Domingo E Uceda; Xiang-Yang Zhu; John R Woollard; Christopher M Ferguson; Ioannis Patras; Daniel F Carlson; Samuel J Asirvatham; Amir Lerman; Lilach O Lerman
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-03-19

3.  Routine 18F-FDG PET/CT does not detect inflammation in the left atrium in patients with atrial fibrillation.

Authors:  Nemanja Avramovic; Lars Eckardt; Christian Wenning; Philipp S Lange; Gerrit Frommeyer; Kristina Wasmer; Christian Pott
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-22       Impact factor: 2.357

4.  Pre-operative serum VCAM-1 as a biomarker of atrial fibrillation after coronary artery bypass grafting.

Authors:  Leanne Harling; Jonathan Lambert; Hutan Ashrafian; Ara Darzi; Nigel J Gooderham; Thanos Athanasiou
Journal:  J Cardiothorac Surg       Date:  2017-08-18       Impact factor: 1.637

5.  Pericardial fat volume and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis and Jackson Heart Study.

Authors:  Susan R Heckbert; Kerri L Wiggins; Chad Blackshear; Yi Yang; Jingzhong Ding; Jiankang Liu; Barbara McKnight; Alvaro Alonso; Thomas R Austin; Emelia J Benjamin; Lesley H Curtis; Nona Sotoodehnia; Adolfo Correa
Journal:  Obesity (Silver Spring)       Date:  2017-04-28       Impact factor: 5.002

6.  Inflammatory activity of adipose tissue.

Authors:  Şahin İşcan; İsmail Yürekli; Habib Çakır; Orhan Gökalp
Journal:  Anatol J Cardiol       Date:  2017-04       Impact factor: 1.596

Review 7.  Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges.

Authors:  Ioan Tilea; Andreea Varga; Razvan Constantin Serban
Journal:  Diagnostics (Basel)       Date:  2021-05-15

8.  Serum Soluble Semaphorin 4D is Associated with Left Atrial Diameter in Patients with Atrial Fibrillation.

Authors:  Li Xiang; Tao You; Jianchang Chen; Weiting Xu; Yang Jiao
Journal:  Med Sci Monit       Date:  2015-09-29

9.  Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial.

Authors:  Roopinder K Sandhu; Justin A Ezekowitz; Ziad Hijazi; Johan Westerbergh; Julia Aulin; John H Alexander; Christopher B Granger; Sigrun Halvorsen; Michael S Hanna; Renato D Lopes; Agneta Siegbahn; Lars Wallentin
Journal:  Open Heart       Date:  2018-11-01

10.  Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery.

Authors:  Marinela Couselo-Seijas; José N Lopez-Canoa; Ángel L Fernandez; Laila González-Melchor; Luisa M Seoane; Darío Duran-Muñoz; Adriana Rozados-Luis; José Ramón González-Juanatey; Moisés Rodríguez-Mañero; Sonia Eiras
Journal:  J Cell Mol Med       Date:  2020-08-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.